Screening for type 2 diabetes and prediabetes in obese youth: Evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin

Pediatric Diabetes

Volumn 17, Issue 3, 2016, Pages 206-211

  Chan, Christine L ^a   Pyle, Laura ^a   Kelsey, Megan ^a   Newnes, Lindsey ^a   Zeitler, Philip S ^a   Nadeau, Kristen J ^a  

^a CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

1,5 anhydroglucitol; 2 hour post OGTT glucose; Fasting plasma glucose; Fructosamine; Glycated albumin; Hemoglobin A1c; Oral glucose tolerance testing; Prediabetes; Type 2 diabetes

Indexed keywords

1,5 ANHYDROSORBITOL; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; 1,5-ANHYDROGLUCITOL; BIOLOGICAL MARKER; DEOXYGLUCOSE; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ADOLESCENT; ADULT; ARTICLE; BLACK PERSON; BODY MASS; CAUCASIAN; CHILD; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; PREDIABETIC STATE; PROCEDURES;

ADOLESCENT; BIOMARKERS; CHILD; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FRUCTOSAMINE; HUMANS; MALE; MASS SCREENING; OBESITY; PREDIABETIC STATE; SERUM ALBUMIN;

EID: 84922567806     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12258     Document Type: Article

References (27)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012: 307: 483-490.
2. Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2011 Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011 (available from http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf)
3. Lee JM, Wu EL, Tarini B, Herman WH, Yoon E. Diagnosis of diabetes using hemoglobin A1c: Should recommendations in adults be extrapolated to adolescents? J Pediatr 2011: 158: 947.e1-3-952.e1-3.
4. Lippi G, Targher G. A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties? Pediatr Diabetes 2011: 12: 183-186.
5. Love-Osborne KA, Sheeder J, Svircev A, Chan C, Zeitler P, Nadeau KJ. Use of glycosylated hemoglobin increases diabetes screening for at-risk adolescents in primary care settings. Pediatr Diabetes 2013: 14: 512-518.
6. Malkani S, DeSilva T. Controversies on how diabetes is diagnosed. Curr Opin Endocrinol Diabetes Obes 2012: 19: 97-103.
7. Nowicka P, Santoro N, Liu H et al. Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 2011: 34: 1306-1311.
8. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008: 93: 4231-4237.
9. Ahmad J, Rafat D. HbA1c and iron deficiency: a review. Diabetes Metab Syndr 2013: 7: 118-122.
10. Godbout A, Hammana I, Potvin S et al. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes Metab 2008: 34: 568-573.
11. Chan CL, McFann K, Newnes L, Nadeau KJ, Zeitler PS, Kelsey M. Hemoglobin A1c assay variations and implications for diabetes screening in obese youth. Pediatr Diabetes 2014: 15: 557-563.
12. Lee JM, Eason A, Nelson C, Kazzi NG, Cowan AE, Tarini BA. Screening practices for identifying type 2 diabetes in adolescents. J Adolesc Health 2014: 54: 139-143.
13. Dungan KM, Buse JB, Largay J et al. 1, 5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 2006: 29: 1214-1219.
14. Shah S, Kublaoui BM, Oden JD, White PC. Screening for type 2 diabetes in obese youth. Pediatrics 2009: 124: 573-579.
15. Yamanouchi T, Ogata N, Tagaya T et al. Clinical usefulness of serum 1, 5-anhydroglucitol in monitoring glycaemic control. Lancet 1996: 347: 1514-1518.
16. Yamanouchi T, Akanuma Y, Toyota T et al. Comparison of 1, 5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes 1991: 40: 52-57.
17. Yoshiuchi K, Matsuhisa M, Katakami N et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 2008: 55: 503-507.
18. Lee JM, Gebremariam A, Wu EL, LaRose J, Gurney JG. Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia. Diabetes Care 2011: 34: 2597-2602.
19. Nathan DM, McGee P, Steffes MW, Lachin JM, Group DER. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes 2014: 63: 282-290.
20. Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA. Serum 1, 5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes 2007: 8: 214-219.
21. Tietz NWe. Clinical Guide to Laboratory Tests. 3rd edn. Philadelphia, PA: W.B. Saunders, CO., 1995.
22. Marks V, Cantor T, Mesko D, Pullmann R, Nosalova G. Differential Diagnosis by Laboratory Medicine: A Quick Reference for Physicians. Verlag Berlin Heidelberg, Germany, Springer, 2003.
23. Furusyo N, Koga T, Ai M et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia 2011: 54: 3028-3036.
24. Kohzuma T, Yamamoto T, Uematsu Y, Shihabi ZK, Freedman BI. Basic performance of an enzymatic method for glycated albumin and reference range determination. J Diabetes Sci Technol 2011: 5: 1455-1462.
25. Suzuki S, Koga M, Niizeki N et al. Age-adjusted glycated albumin: a more robust parameter to establish glycaemic control in neonatal diabetes mellitus. Ann Clin Biochem 2014: 51: 602-605.
26. Williams DE, Cadwell BL, Cheng YJ et al. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics 2005: 116: 1122-1126.
27. Baranowski T, Cooper DM, Harrell J et al. Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care 2006: 29: 212-217.